Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.683,58
0,30%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Gsk Plc (GSK) Gsk Plc (GSK) Notizie

GSK

Gsk (GSK)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:GSK
DataOraFonteTitoloSimboloCompagnia
24/05/202409:36Alliance NewsAlliance NewsTOP NEWS: GSK celebrates Illinois jury verdict in Valadez caseLSE:GSKGsk Plc
24/05/202408:00RNS Regulatory NewsGSK PLC Statement: Zantac (ranitidine) litigationLSE:GSKGsk Plc
21/05/202409:49Alliance NewsAlliance NewsGSK's depemokimab asthma treatment meets endpoints in latest trialsLSE:GSKGsk Plc
21/05/202408:00RNS Regulatory NewsGSK PLC Positive phase III asthma results for depemokimabLSE:GSKGsk Plc
20/05/202417:11Alliance NewsAlliance NewsIN BRIEF: GSK executive buys GBP20,026 worth sharesLSE:GSKGsk Plc
20/05/202416:30RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
17/05/202410:03Alliance NewsAlliance NewsTOP NEWS: GSK sells remaining Haleon stake for GBP1.25 billionLSE:GSKGsk Plc
17/05/202408:00RNS Regulatory NewsGSK PLC GSK completes sale of shares in Haleon plcLSE:GSKGsk Plc
16/05/202418:13Alliance NewsAlliance NewsTOP NEWS: GSK to sell remaining holding in spin-off HaleonLSE:GSKGsk Plc
16/05/202417:42RNS Regulatory NewsGSK PLC GSK announces intention to sell shares in HaleonLSE:GSKGsk Plc
13/05/202416:00RNS Regulatory NewsGSK PLC Block listing Interim ReviewLSE:GSKGsk Plc
08/05/202419:21RNS Regulatory NewsGSK PLC Result of AGMLSE:GSKGsk Plc
08/05/202417:57RNS Regulatory NewsGSK PLC Board Committee ChangeLSE:GSKGsk Plc
01/05/202416:00RNS Regulatory NewsGSK PLC Total Voting RightsLSE:GSKGsk Plc
01/05/202409:50Alliance NewsAlliance NewsTOP NEWS: GSK expects momentum to continue after strong first quarterLSE:GSKGsk Plc
01/05/202408:00RNS Regulatory NewsGSK PLC 1st Quarter ResultsLSE:GSKGsk Plc
24/04/202410:14Alliance NewsAlliance NewsGSK's Jemperli with chemotherapy accepted for priority review by FDALSE:GSKGsk Plc
24/04/202408:00RNS Regulatory NewsGSK PLC US FDA accepts new indication filing for JemperliLSE:GSKGsk Plc
17/04/202409:46Alliance NewsAlliance NewsTOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea treatmentLSE:GSKGsk Plc
17/04/202408:05RNS Regulatory NewsGSK PLC GSK announces additional EAGLE-1 resultsLSE:GSKGsk Plc
17/04/202408:00RNS Regulatory NewsGSK PLC Results from long-term data relating to ShingrixLSE:GSKGsk Plc
16/04/202415:11RNS Regulatory NewsGSK PLC Amendment - Director/PDMR ShareholdingLSE:GSKGsk Plc
16/04/202409:59Alliance NewsAlliance NewsGSK's latest meningitis vaccine accepted for review by US regulatorLSE:GSKGsk Plc
16/04/202408:00RNS Regulatory NewsGSK PLC FDA accepts GSK meningitis vaccine candidate fileLSE:GSKGsk Plc
08/04/202411:27Alliance NewsAlliance NewsIN THE KNOW: Barclays ups GSK price target but HIV drug nerves remainLSE:GSKGsk Plc
04/04/202413:05RNS Regulatory NewsGSK PLC Replacement - Total Voting RightsLSE:GSKGsk Plc
25/03/202414:00RNS Regulatory NewsGSK PLC Notice of AGMLSE:GSKGsk Plc
22/03/202417:20RNS Regulatory NewsGSK PLC Transfer of Treasury SharesLSE:GSKGsk Plc
18/03/202410:30RNS Regulatory NewsGSK PLC New Phase III Jemperli data in endometrial cancerLSE:GSKGsk Plc
18/03/202409:47Alliance NewsAlliance NewsGSK says Jemperli combination gets good results for endometrial cancerLSE:GSKGsk Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:GSK

La tua Cronologia

BOV
VIVA3
VIVARA ON
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network